| Application no. and date | 14803277.4 (espacenet) (Federated) (European Patent Register), 20141031 | | Patent/reg. no. and date | DK/EP 3065770, 20201028 | | Publication date | 20160914 | | Priority no. and date | US 201361900226 P, 20131105 | | EP pub. no. and date |
EP 3065770 20160914 | | Effective date | | | Applicant/owner | BAVARIAN NORDIC A/S, Philip Heymans Alle 3, 2900 Hellerup, DK | | Applicant ref. no. | 1563974 | | Inventor | DELCAYRE, Alain, 2812 Lexford Avenue
San Jose, CA 95124, US,
ROUNTREE, Ryan, 4029 Briarglen Drive
San Jose, CA 95118, US,
FOY, Susan, 504 Franklin Street
Mountain View, CA 94041, US,
MANDL, Stefanie, 1384 34th Avenue
San Francisco, CA 94122, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 39/00 (2006.01) , A61P 35/00 (2006.01) | | Title | KOMBINATIONSTERAPI TIL BEHANDLING AF CANCER MED ET POXVIRUS, DER UDTRYKKER ET TUMORANTIGEN OG EN ANTAGONIST AF EN IMMUNCHECKPOINT-INHIBITOR | | Int. application no. | US2014063516 | | Int. publication no. | WO2015069571 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
